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[Rh(HDPA)(chrysi)(diethyl-2-(2-(di(pyridin-2-yl)amino)acetamido)malonate]
(TFA) 3 [Rh(HDPA)(chrysi)(dpa-AcOH](TFA) 3 
[Rh(HDPA)(chrysi)(2-(2-(di(pyridin-2-yl)amino)acetamido)-3-ethoxy-3-oxopropanoic acid)] (TFA) 3 ("Rh(Amal)") (2)
To hydrolyze the ethyl esters, [Rh(HDPA)(chrysi)(diethyl-2-(2-(di(pyridin-2-yl)amino)acetamido)malonate] (TFA) 3 (41 mg, 0.033 mmol) was dissolved in a 5:1 H 2 O:EtOH mixture (12 ml). 1N NaOH was added to pH 10, and the reaction was stirred at room temperature for 24 h. The solvent was removed by rotary evaporation, and Rh(Amal) was purified by HPLC as described above. The chloride salt was obtained from a Sephadex QAE anion-exchange column equilibrated with 0. 
Photocleavage Competition Titrations
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The samples were then incubated at 37 °C for 10 minutes to degrade any metastable products and dried under vacuum. The irradiated samples were electrophoresed on a 20%
denaturing polyacrylamide gel and exposed to a phosphor screen. The amounts of DNA in each band were analyzed by autoradiography and quantitated by phosphorimagery (ImageQuant).
Binding Constant Determination
As the RhPt complex does not photocleave DNA upon irradiation, the binding affinity for a CC mismatch was determined via a competition titration against rac- 
Cell Culture
HCT116O. HCT116O cells were grown in RPMI medium 1640 supplemented with 10% fetal bovine serum, 400 µg/ml Geneticin (G418), 2 mM L-glutamine, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 100 units/ml penicillin, and 100 µg/ml streptomycin. Cells were grown in tissue culture flasks (Corning Costar, Acton, MA) at 37 °C under a humidified atmosphere (5% CO 2 ).
Cellular Proliferation ELISA
The antiproliferative effects of conjugate RhPt, oxaliplatin, cisplatin, Rh(Amal) and 
ICP-MS Assay for Nuclear Rh and Pt Levels
HCT116O cells were plated at 1.0 x 10 7 cells in 10 ml media and incubated for 24
h. The cells were treated with 2 µM of RhPt, Rh(Amal), Pt(Amal), cisplatin, or oxaliplatin and incubated for an additional 24 h. The cells were harvested by trypsinization, washed with cold PBS, and the nuclear fractions were isolated according to established procedures. 6 The nuclear pellets were suspended in 800 µl of Milli-Q water and sonicated on a Qsonica Ultrasonic processor for 20 s at 40% amplitude. A 750 µl aliquot was diluted with 750 µl of a 2% HNO 3 (v/v) solution and analyzed for rhodium and platinum content on a Thermo X Series II ICP-MS unit as previously described. The remainder of each sample was used for quantification of nuclear protein content by BCA analysis. The protein content was then converted to number of nuclei by the conversion factor 3.28 x 10 -8 mg [nuclear protein]/nuclei. 6 Rhodium and platinum counts were then normalized to the number of nuclei, and standard errors were calculated from three replicates.
ICP-MS Assay for Mitochondrial Rh and Pt Levels
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HCT116O cells were plated at 1.5 x 10 7 cells/plate and allowed 24h to adhere. The cells were treated with 2 µM of RhPt, Rh(Amal), Pt(Amal), cisplatin, or oxaliplatin and incubated for an additional 24 h. The cells were harvested by trypsinization, washed with cold PBS, and the mitochondrial fractions were isolated according to established procedures. 6 The mitochondrial pellets were suspended in 800 µl of Milli-Q water and 
MTT Cytotoxicity Assay
The cytotoxic effects of conjugate RhPt, Rh(Amal), Pt(Amal), oxaliplatin, and cisplatin were studied via MTT ( 
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